These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 16936439)

  • 21. Therapeutic time window for edaravone treatment of traumatic brain injury in mice.
    Miyamoto K; Ohtaki H; Dohi K; Tsumuraya T; Song D; Kiriyama K; Satoh K; Shimizu A; Aruga T; Shioda S
    Biomed Res Int; 2013; 2013():379206. PubMed ID: 23710445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventive effects of edaravone, a free radical scavenger, on lipopolysaccharide-induced lung injury in mice.
    Tajima S; Soda M; Bando M; Enomoto M; Yamasawa H; Ohno S; Takada T; Suzuki E; Gejyo F; Sugiyama Y
    Respirology; 2008 Sep; 13(5):646-53. PubMed ID: 18713088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotective effects of edaravone on cognitive deficit, oxidative stress and tau hyperphosphorylation induced by intracerebroventricular streptozotocin in rats.
    Zhou S; Yu G; Chi L; Zhu J; Zhang W; Zhang Y; Zhang L
    Neurotoxicology; 2013 Sep; 38():136-45. PubMed ID: 23932983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Edaravone attenuates intracerebroventricular streptozotocin-induced cognitive impairment in rats.
    Reeta KH; Singh D; Gupta YK
    Eur J Neurosci; 2017 Apr; 45(7):987-997. PubMed ID: 28199036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term efficacy of edaravone in patients with acute myocardial infarction.
    Tsujita K; Shimomura H; Kaikita K; Kawano H; Hokamaki J; Nagayoshi Y; Yamashita T; Fukuda M; Nakamura Y; Sakamoto T; Yoshimura M; Ogawa H
    Circ J; 2006 Jul; 70(7):832-7. PubMed ID: 16799234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prophylactic Edaravone Prevents Transient Hypoxic-Ischemic Brain Injury: Implications for Perioperative Neuroprotection.
    Sun YY; Li Y; Wali B; Li Y; Lee J; Heinmiller A; Abe K; Stein DG; Mao H; Sayeed I; Kuan CY
    Stroke; 2015 Jul; 46(7):1947-55. PubMed ID: 26060244
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of edaravone, a free-radical scavenger, on bleomycin-induced lung injury in mice.
    Tajima S; Bando M; Ishii Y; Hosono T; Yamasawa H; Ohno S; Takada T; Suzuki E; Gejyo F; Sugiyama Y
    Eur Respir J; 2008 Nov; 32(5):1337-43. PubMed ID: 18614556
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Edaravone protects against ischemia/reperfusion-induced oxidative damage to mitochondria in rat liver.
    Okatani Y; Wakatsuki A; Enzan H; Miyahara Y
    Eur J Pharmacol; 2003 Mar; 465(1-2):163-70. PubMed ID: 12650846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Attenuation of axonal injury and oxidative stress by edaravone protects against cognitive impairments after traumatic brain injury.
    Ohta M; Higashi Y; Yawata T; Kitahara M; Nobumoto A; Ishida E; Tsuda M; Fujimoto Y; Shimizu K
    Brain Res; 2013 Jan; 1490():184-92. PubMed ID: 22982593
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of neointimal hyperplasia development by MCI-186 is correlated with downregulation of nuclear factor-kappaB pathway.
    Radhakrishnan G; Suzuki R; Maeda H; Yamamoto M; Hirose N; Gopalrao RK; Lee GH; Hayashi Y; Rao P; Sasaguri S
    Circ J; 2008 May; 72(5):800-6. PubMed ID: 18441462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the role of breast cancer resistance protein (BCRP/ABCG2) and multidrug resistance-associated protein 4 (MRP4/ABCC4) in the urinary excretion of sulfate and glucuronide metabolites of edaravone (MCI-186; 3-methyl-1-phenyl-2-pyrazolin-5-one).
    Mizuno N; Takahashi T; Kusuhara H; Schuetz JD; Niwa T; Sugiyama Y
    Drug Metab Dispos; 2007 Nov; 35(11):2045-52. PubMed ID: 17682070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice.
    Koulis C; Chen YC; Hausding C; Ahrens I; Kyaw TS; Tay C; Allen T; Jandeleit-Dahm K; Sweet MJ; Akira S; Bobik A; Peter K; Agrotis A
    Arterioscler Thromb Vasc Biol; 2014 Mar; 34(3):516-25. PubMed ID: 24436372
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis of the metabolites of a free radical scavenger edaravone (MCI-186, Radicut).
    Watanabe K; Taniguchi M; Shinoda M
    Redox Rep; 2003; 8(3):157-61. PubMed ID: 12935313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repeated edaravone treatment reduces oxidative cell damage in rat brain induced by middle cerebral artery occlusion.
    Yamamoto Y; Yanagisawa M; Tak NW; Watanabe K; Takahashi C; Fujisawa A; Kashiba M; Tanaka M
    Redox Rep; 2009; 14(6):251-8. PubMed ID: 20003710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Edaravone improves the expression of nerve growth factor in human astrocytes subjected to hypoxia/reoxygenation.
    Yoshida H; Metoki N; Ishikawa A; Imaizumi T; Matsumiya T; Tanji K; Ota K; Ohyama C; Satoh K
    Neurosci Res; 2010 Mar; 66(3):284-9. PubMed ID: 19954754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of 3-methyl-1-phenyl-2-pyrazolin-5-one, a free radical scavenger, on acute toxicity of paraquat in mice.
    Saibara T; Toda K; Wakatsuki A; Ogawa Y; Ono M; Onishi S
    Toxicol Lett; 2003 Jun; 143(1):51-4. PubMed ID: 12697380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Edaravone reduces early accumulation of oxidative products and sequential inflammatory responses after transient focal ischemia in mice brain.
    Zhang N; Komine-Kobayashi M; Tanaka R; Liu M; Mizuno Y; Urabe T
    Stroke; 2005 Oct; 36(10):2220-5. PubMed ID: 16166574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MCI-186 (edaravone), a free radical scavenger, attenuates ischemia-reperfusion injury and activation of phospholipase A(2) in an isolated rat lung model after 18 h of cold preservation.
    Reyes YA; Shimoyama T; Akamatsu H; Sunamori M
    Eur J Cardiothorac Surg; 2006 Mar; 29(3):304-11. PubMed ID: 16427299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Free radical scavenger edaravone suppresses x-ray-induced apoptosis through p53 inhibition in MOLT-4 cells.
    Sasano N; Enomoto A; Hosoi Y; Katsumura Y; Matsumoto Y; Shiraishi K; Miyagawa K; Igaki H; Nakagawa K
    J Radiat Res; 2007 Nov; 48(6):495-503. PubMed ID: 17965547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of edaravone in heart of aged rats after cerebral ischemia-reperfusion injury.
    Watanabe K; Ma M; Wen J; Kodama M; Aizawa Y
    Biol Pharm Bull; 2007 Mar; 30(3):460-4. PubMed ID: 17329838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.